Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study)

Background: Depressed patients who do not respond to second-line antidepressant drugs are characterised as suffering from treatment-refractory depression (TRD). Chronic psychosocial stress hypothalamic–pituitary–adrenal (HPA) axis dysfunction is associated with attenuated responses to antidepressant...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: I Nicol Ferrier, Ian M Anderson, Jane Barnes, Peter Gallagher, Heinz CR Grunze, Peter M Haddad, Allan O House, Tom Hughes, Adrian J Lloyd, Chrysovalanto Mamasoula, Elaine McColl, Simon Pearce, Najma Siddiqi, Baxi Sinha, Chris Speed, Nick Steen, June Wainwright, Stuart Watson, Fiona H Winter, R Hamish McAllister-Williams, the ADD Study Team
格式: Artigo
語言:Inglês
出版: NIHR Journals Library 2015-06-01
叢編:Efficacy and Mechanism Evaluation
主題:
randomised controlled trial
antiglucocorticoid
augmentation
metyrapone
antidepressants
depression
add study
treatment-refractory depression
在線閱讀:https://doi.org/10.3310/eme02040
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍